Smith opened up about the treatment which she received a month ago and how her migraine symptoms had been reduced as a result ...
Pharmaceutical Technology on MSN
Ipsen set to rival Botox after duo of Phase III migraine wins
The company claims that Dysport is now the first botulinum toxin therapy to demonstrate efficacy in episodic migraine.
Migraine remains one of the most prevalent and disabling neurological disorders, yet many patients continue cycling through ...
In a first for the neurotoxin market, Ipsen announced Thursday that its Dysport has hit the goals in two phase 3 trials for ...
A Central Texas family shares the story of a groundbreaking fetal procedure using Botox that helped their daughter avoid ...
EDE warned that the use of counterfeit products may pose a serious risk to public health Dubai: The Emirates Drug Establishment (EDE) has issued an urgent warning regarding a counterfeit batch of ...
The Establishment said the product was not brought into the UAE through approved import channels. It warned that using counterfeit medical products can be dangerous because they do not meet approved ...
Dhaka’s aesthetic medicine industry is quietly booming. It reflects changing beauty standards, social media influence, and ...
Severity of morning migraine, emerging therapeutic targets, and new drugs for migraine prevention and acute treatment are among the key findings presented at the American Headache Society’s 2026 ...
23don MSN
A dermatologist explains how this humble serum mimics the look of Botox — for just $8 on Prime Day
"Botox in a bottle? They’re not joking." ...
Last week, we published the first of our new monthly rankings: the top 25 local U.S. newspapers on the web, based on their traffic. (All hail the conquering Advance Local!) Today, it’s time for the ...
The ARPA-H program could provide researchers with a roadmap to develop personalized gene editing drugs. Elsewhere, a Botox ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results